Skip to content
Menu

SELLAS Life Sciences Group, Inc. SLS

Full chart Compare
Set alert

Price alert · SLS

All alert types
14.86 USD -3.09 (-17.21%)

Regular-session close

14.67 -0.19 -1.28%

Pre-market · Nov 20, 4:10 AM ET

14.23 Day range 16.54
1.39 52-week range 24.89
YTD
+294.16%
1 year
+877.63%

Revenue & Expenses

Revenue Profit Costs
Other Income$649.00KGross Profit$900.00KNet Loss$41.30MCost of Revenue$100.00KExpenses$42.85MSelling, General & Admin$12.58MResearch & Development$30.27MRevenue$1.00M

Latest period ending Dec 31, 2025 · select a line to chart its full history

SLS annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-28.27M-31.51M-37.87M-41.95M-25.29M
-26.86M-30.88M-37.34M-41.30M-20.70M
-0.25-0.50-1.34-2.13-1.34
SLS annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
71.89M13.99M2.63M17.23M21.45M
78.34M19.43M6.22M20.94M26.27M
7.47M9.97M14.20M16.09M5.93M
1.00M1.00M906.00K945.00K808.00K
70.87M9.46M-7.98M4.85M20.35M
SLS annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-28.39M-35.40M-31.41M-23.81M-26.02M
86.30M46.76M22.32M24.08M12.07M
57.91M11.36M-14.60M-4.23M-13.95M